Haemonetics Corp. buy Needham & Company LLC
Start price
03.12.24
/
50%
€80.50
Target price
03.12.25
€106.36
Performance (%)
-47.33%
Price
13.10.25
€42.40
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Haemonetics Corp. is performing very badly with a performance of -47.33%. This prediction currently runs until 03.12.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | -1.442% | -1.442% |
| iShares Core DAX® | -0.074% | 2.983% |
| iShares Nasdaq 100 | 0.311% | 4.215% |
| iShares Nikkei 225® | -3.548% | 4.061% |
| iShares S&P 500 | -0.057% | 2.602% |
Comments by Needham___Company_LL for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Needham___Company_LL for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€49.00
07.08.25
07.08.25
€58.31
07.08.26
07.08.26
-13.47%
13.10.25
13.10.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€60.00
08.05.25
08.05.25
€74.16
08.05.26
08.05.26
-29.33%
13.10.25
13.10.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€58.50
18.03.25
18.03.25
€95.28
18.03.26
18.03.26
-27.52%
13.10.25
13.10.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.00
07.02.25
07.02.25
€104.18
07.02.26
07.02.26
-25.61%
13.10.25
13.10.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€84.00
15.11.24
15.11.24
€106.41
15.11.25
15.11.25
-49.52%
13.10.25
13.10.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€79.00
12.06.24
12.06.24
€103.42
12.06.25
12.06.25
-24.68%
13.06.25
13.06.25